Bengaluru, September 2026 — In a chilling betrayal of medical trust, a massive fake cancer drug racket has been dismantled in Bengaluru, exposing a life-threatening supply chain that silently infiltrated the city’s healthcare system.

What officials describe as a highly organized criminal enterprise thrived on the desperation of patients and the cost-cutting measures of medical facilities, putting countless lives at risk.

The Deadly “Discount” For years, the syndicate successfully supplied counterfeit medications to over 90 hospitals and clinics across Bengaluru. The primary bait used to infiltrate these medical supply chains was a massive 50% discount on expensive, life-saving cancer drugs. While hospital procurement teams believed they were securing a bargain, vulnerable patients were being administered compromised, ineffective treatments.

A Pharmacist’s Betrayal The mastermind behind this lethal operation was not an outsider, but a licensed professional. Authorities revealed that the racket was orchestrated by a licensed pharmacist named Veeresh Jain. Using his official credentials and industry knowledge as a shield, Jain successfully kept his illicit enterprise running under the radar for nearly five years.

The Modus Operandi: Expired and Repackaged The syndicate’s methods were as sophisticated as they were sinister. The operation did not solely rely on manufacturing completely fake chemical mixtures. Instead, a major part of the scam involved acquiring expired medications.

These useless—and potentially toxic—drugs were systematically stripped of their original packaging, transferred into fresh containers, and slapped with highly accurate, counterfeit labels mimicking established and trusted pharmaceutical brands. To doctors and nurses on the ward, the vials appeared perfectly authentic.

The ₹4.91 Crore Bust The illusion finally shattered when Karnataka’s drug control officials executed a coordinated raid on the syndicate’s unlicensed manufacturing facility. During the crackdown, authorities dismantled the core of the operation, seizing illicit machinery, containers, and packaging equipment valued at a staggering ₹4.91 crore.

Uncovering the Wider Web Because the racket successfully bypassed medical safety checks for half a decade, the state has formed a Special Investigation Team (SIT). The SIT’s immediate mandate is to trace the wider network—investigating the distributors, middlemen, and potentially complicit hospital staff who allowed these fake drugs to reach patient IVs unchecked.

Bottom Line The Bengaluru fake drug bust exposes a terrifying blind spot in medical procurement. For five years, a licensed professional weaponized his credentials to sell false hope to cancer patients while quietly draining their wallets and their health. With the SIT now digging into the supply chain, the masks are off: in the business of life-saving medicine, a discount that looks too good to be true can ultimately be fatal.